Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026

January 2016 | 54 pages | ID: E267CF46BFDEN
Black Swan Analysis limited

Abstracts

Pancreatic cancer is one of the most deadly cancers in the world. Pancreatic cancer is a result of malignant cells forming in the tissue of the pancreas, and typically spreads rapidly with detection usually in the later stages of the disease. The prognosis of pancreatic cancer, especially for later stages, is quite poor and has the lowest survival rate of all cancers.
This report provides the current incidence population for Pancreatic Cancer across 17 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Mexico, Turkey, Canada, Australia, South Africa, Saudi Arabia, Argentina, and Russia) split by gender and 5-year age cohort. Along with the current incidence, the report provides an overview of the stages, locations and histopathology of Pancreatic Cancer tumours. These sub-populations within the main disease are included at a country level across a 10-year forecast snapshot.
Main symptoms and co-morbidities for Pancreatic Cancer include:
• Obesity
• Diabetes
• Jaundice
• Pancreatitis
• Gallbladder enlargement

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
• Able to quantify patient populations in global Pancreatic Cancer’s market to target the development of future products, pricing strategies and launch plans.
• Gain further insight into the incidence of the subdivided types of Pancreatic Cancer and identify patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Identify sub-populations within Pancreatic Cancer which require treatment.
• Gain an understanding of the specific markets that have the largest number of Pancreatic Cancer patients.

Contents

Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/ Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Incidence for Pancreatic Cancer
Stages and Location of Pancreatic Cancer
  Staging of Pancreatic Cancer
  Histopathology of Pancreatic Cancer
  Pancreatic Cancer Tumour Location
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix

List Of Tables

LIST OF TABLES

AJCC Tumour Staging Classification for Pancreatic Cancer
Incidence of Pancreatic Cancer, total (000s)
Incidence of Pancreatic Cancer, males (000s)
Incidence of Pancreatic Cancer, females (000s)
AJCC Stages of Pancreatic Cancer patients, total (000s)
Major Histopathological type in Pancreatic Cancer, total (000s)
Tumour location in Pancreatic Cancer patients, total (000s)
Abbreviations and Acronyms used in the report
USA Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
USA Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
France Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
France Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Germany Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Germany Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Italy Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Italy Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Spain Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Spain Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
UK Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
UK Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Brazil Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Japan Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Japan Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
India Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
India Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Australia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Australia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Canada Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Canada Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
MexicoIncidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
MexicoIncidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Turkey Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
South Africa Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Saudi Arabia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Argentina Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)
Russia Incidence of Pancreatic Cancer by 5-yr age cohort, males (000s)
Russia Incidence of Pancreatic Cancer by 5-yr age cohort, females (000s)